Comparison of the Middle molecule clearance in patients of chronic kidney disease (CKD) undergoing Renal Replacement Therapy by different modalities
Not Applicable
- Conditions
- Health Condition 1: N17-N19- Acute kidney failure and chronic kidney disease
- Registration Number
- CTRI/2022/10/046910
- Lead Sponsor
- DGAFMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Eligible adults of CKD 5D aged at least 18 years of age who have been initiated on any one of the two modalities of dialysis
Individual should have functional AV fistula with blood flow more than 300 ml/min
Exclusion Criteria
Patients not having AV Fistula as vascular access in HDF and HD group
2. Patients not giving written informed consent will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method